CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2009; 30(02): 76-79
DOI: 10.4103/0971-5851.60052
ORIGINAL ARTICLE

Three patients with both Hodgkin′s lymphoma and Castleman′s disease: Clinicopathologic correlations and lack of association with HHV-8

Saadiya Haque
Georgetown University Hospital, 3900 Reservoir Road, Washington, DC 20007, USA
,
Robert van Kirk Jr
Prince Williams Hospital, 8700 Sudley Road, Manassas, VA 20110, USA
› Author Affiliations

Abstract

Background : The relationship between Hodgkin′s lymphoma (HL) and plasma cell-type Castleman′s disease (PCD) has been well documented. There have been over 20 cases reported in the literature and nearly all of them were either diagnosed concurrently, or were initially diagnosed as PCD and upon review were found to have interfollicular HL. Human herpes virus type 8 (HHV-8) is present in about 40% of cases with PCD. It predisposes patients to a much higher risk of other malignancies, including Kaposi′s sarcoma and non-Hodgkin′s lymphoma. Cases linked to HHV-8 are associated with a different morphology than cases that are not linked to HHV-8. It has been proposed that patients with both HL and CD will have lymph nodes with HHV-8-negative morphology.Materials and Methods : We present a series of three cases in a retrospective study where patients had both HL and PCD. Surgical pathology reports, clinical histories, and H and E and various immunohistochemical stains on initial work-up were examined and subsequent immunohistochemical stains for HHV-8 were obtained from the Methodist Hospital.Results:Patient 1 was diagnosed with PCD and interfollicular HL in the same lymph node. Patient 2 was first diagnosed with classic HL and 2 years later returned with enlarged lymph nodes clinically suspected to be recurrent HL. Histology showed angiofollicular hyperplasia and interfollicular plasmacytosis without Reed-Sternberg cells and a diagnosis of PCD was rendered. Patient 3, a male in his third decade, was diagnosed with nodular sclerosing HL in the thymus, and concurrently PCD in the mediastinal lymph nodes. All three cases had architectural features consistent with an HHV-8-negative morphology. Immunohistochemical stains for HHV-8 were done retrospectively and were negative.Conclusion:All three of our patients with both HL and CD had HHV-8-negative lymph node morphology and absence of HHV-8 by immunohistochemistry. These patients, therefore, are not at an increased risk for the development of subsequent malignancies, when compared to HHV-8-positive patients. Included in our series is one unique case where the diagnosis of HL preceded CD by 2 years.



Publication History

Article published online:
19 November 2021

© 2009. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Castleman B. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9:822-30.
  • 2 Amin HM, Medeiros LJ, Manning JT, Jones D. Dissolution of lymphoid follicle is a feature of the HHV8+ variant of Castleman′s disease. Am J Surg Pathol 2003;27:91-100.
  • 3 Abdel-Reheim FA, Koss W, Rappaport ES, Arber DA. Coexistence of Hodgkin′s disease and giant lymph node hyperplasia of the plasma cell type (Castleman′s disease). Arch Pathol Lab Med 1996;120:91-6.
  • 4 Frank DK, Charney D, Kashani A. Plasma cell variant of Castleman′s disease occurring concurrently with Hodgkin′s disease in the neck. Head Neck 2001;23:166-9.
  • 5 Maheswaran PR, Ramsay AD, Norton AJ, Roche WR. Hodgkin′s disease presenting with histological features of Castleman′s disease. Histopathology 1991;18:249-53.
  • 6 Zanetto U, Pagani FP, Perez C. Interfollicular Hodgkin′s lymphoma and Castleman′s disease. Histopathology 2006;48:317-9.
  • 7 Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS. Hodgkin′s disease with coexistent Castleman-like histologic features. Arch Pathol Lab Med 1994;118:270-4.
  • 8 Caussinus E, Meggetto F, Delsol G, Brousset P. Simultaneous occurrence of Epstein Barr virus associated Hodgkin′s disease and HHV-8 related multicentric Castleman′s disease: A fortuitous event? J Clin Pathol 2001;54:790-1.
  • 9 Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, et al. Castleman′s disease and lymphoma: Report of eight cases in HIV-negative patients and literature review. Am J Hematol 2002;69:119-26.
  • 10 Hsu SM, Waldron JA, Xie SS, Barlogie B. Expression of interleukin-6 in Castleman′s disease. Hum Pathol 1993;24:833-9.
  • 11 Hsu SM, Xie SS, Hsu Pl, Waldron JA. Interleukin-6, but not Interleukin-4, is expressed in Reed-Sternberg′s cells in Hodgkin′s disease with or without histologic features of Castleman′s disease. Am J Pathol 1992;141:129-38.
  • 12 Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, van Damme J, et al. Interleukin-6 gene expression in Castleman′s disease. Blood 1991;78:2923-30.
  • 13 Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, Friedman-Kien AE, et al. Human herpes virus 8 encodes a homolog of Interleukin-6. J Virol 1997;71:839-42.